SCHEMBL7618932

SCHEMBL7618932

Clc1cc2c(NCCc3ccc4c(c3)OCO4)ncnc2s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 12/20 0.57
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
ALDH1A1 P00352 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
NPC1 O15118 1/20 0.47
GALR3 O60755 1/20 0.47
NR2F2 P24468 1/20 0.47
RAB9A P51151 1/20 0.47
CLK4 Q9HAZ1 4/20 0.46
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
CLK1 P49759 2/20 0.45
PDE2A O00408 1/20 0.45
PDE1A P54750 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5129003 0.85 BCDIN3D (0.46) PDE5AMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7617647 0.80 PDE5A (0.52) PDE5AMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL5117565 0.79 PRKCI (0.48) PDE5AMEN1KMT2AALDH1A1CLK4
SCHEMBL5129787 0.79 METAP1 (0.47) PDE5AKMT2AALDH1A1SMN1; SMN2NPC1
SCHEMBL5122859 0.79 BCDIN3D (0.43) PDE5AMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL5122882 0.78 BCDIN3D (0.41) PDE5AMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL5128694 0.78 BCDIN3D (0.40) PDE5AMEN1KMT2AMAPT
SCHEMBL16997374 0.77 PDE5A (0.78) PDE5AMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL16997381 0.77 PDE5A (0.59) PDE5AMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL5780434 0.77 PDE5A (0.41) PDE5AMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6432950-B1 ANTICANCER AGENTS; KILLING CANCER CELLS CELL PATHWAYS 2002-08-13 US disclosed
US-6133271-A Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives CELL PATHWAYS, INC. (US) 2000-10-17 US disclosed